Phase I Study of PN401, Fluorouracil, Leucovorin and CPT-11 in Patients With Solid Tumors

NCT00044785 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

24

Enrollment

INDUSTRY

Sponsor class

Conditions

Solid Tumors

Interventions

DRUG: triacetyluridine
DRUG: fluorouracil
DRUG: leucovorin
DRUG: camptosar

Sponsor

Wellstat Therapeutics